(Q73706623)
Statements
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease (English)
S R Targan
F Cornillie
D Shealy
G D'Haens
K Geboes
G Van Assche
C Wagner
T Schaible